Gushen Antai pill to improve IVF ongoing pregnancy rates
Part of Women’s health & pregnancy clinical trials.
This trial studies whether a traditional Chinese medicine pill (Gushen Antai) can improve the chance of an IVF pregnancy that continues (“ongoing pregnancy rate”) and assess its safety. It’s for people starting their first IVF/ICSI cycle with normal ovarian function reserve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your egg levels are in a normal range: AFC between 5 and 15 and AMH between 1.2 and 3.5.
- You have regular periods (about every 21–35 days) and normal ovulation.
- You are doing your first IVF or ICSI cycle (not a later treatment cycle).
- There is at least one embryo or blastocyst ready for transfer.
- You are under 43 years old and your BMI is under 28.
- You are using a standard IVF approach (not freeze-all, natural-cycle, or mild stimulation), and you do not have certain major fertility-related diagnoses (like PCOS or specific genetic/planned testing procedures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
This trial compares two ways of taking a medication that helps control your hormones during IVF (in vitro fertilization), one as a pill and one as an injection, to see if the pill works just as well. It also includes a third group who get a different type of hormone treatment. This could help make IVF more convenient for you.
This study tests whether a traditional Chinese medicine pill, Zishen Yutai, can help people who have had repeated failed embryo transfers. It aims to see if taking this pill improves the chance of a successful pregnancy.
This trial tests a Chinese herbal medicine called Shoutai pills to see if it can improve ovarian function in women with reduced ovarian reserve who are planning IVF. If you qualify, you might get a treatment that could help your eggs mature and improve your chances of success.
This trial studies whether adding acupuncture during embryo transfer and hormone treatment can improve pregnancy outcomes for women who have had repeat IVF implantation failures with no known cause. It may help your chance of clinical pregnancy when you transfer good-quality frozen embryos.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.